Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Pain Symptom Manage. 2019 Jul 2;58(4):605–613. doi: 10.1016/j.jpainsymman.2019.06.024

Table 3.

Study Outcomes for High and Low Dose Fentanyl Sublingual Spray (FSS) Groups

High Dose Group, mean (SD) [95% CI] Low Dose Group, mean (SD) [95% CI]
Variable First walk Second walk Difference P-Value* First walk Second walk Difference P-Value*
Modified Borg Scale: Dyspnea Intensity (primary outcome)
Beginning of walk 0.6 (0.8) 0.7 (1.0) 0.1 (0.5) 0.44 0.5 (0.7) 0.4 (0.8) −0.06 (0.6) 0.84
End of walk 5.1 (1.1) 3.8 (1.4) −1.3 (1.6) 5.1 (2.0) 4.5 (2.1) −0.5 (1.4)
Difference 4.5 (1.7) 3.1 (1.5) −1.4 (1.6)
[−2.4, −0.5]
0.007 4.6 (1.7) 4.1 (2.2) −0.5 (1.6)
[−1.3, 0.3]
0.24
Difference/distance walked (/100 m) 1.5 (0.9) 0.9 (0.7) −0.6 (0.5)
[−0.9, −0.3]
<0.001 1.6 (0.9) 1.3 (0.7) −0.3 (0.5)
[−0.6, −0.1]
0.03
Difference/min walked (/min) 0.8 (0.3) 0.5 (0.3) −0.3 (0.3)
[−0.4, −0.1]
<0.001 0.8 (0.3) 0.7 (0.4) −0.1 (0.2)
[−0.3, −0.008]
0.05
Modified Borg Scale: Dyspnea Unpleasantness
Beginning of walk 0.6 (0.8) 0.7 (1.3) 0.1 (0.7) 0.94 0.4 (1.0) 0.4 (1.0) −0.03 (0.3) >0.99
End of walk 3.9 (1.7) 2.9 (1.9) −1.0 (1.9) 4.1 (2.4) 3.4 (2.8) −0.7 (1.3)
Difference 3.3 (2.0) 2.2 (1.8) −1.0 (1.8) 0.06 3.7 (2.1) 3.0 (2.5) −0.6 (1.4) 0.10
Walk distance (m) 354.6 (155.8) 398.3 (148.7) 43.7 (30.0)
[25.6, 61.8]
0.001 343.2 (148.4) 367.4 (159.6) 24.2 (35.7)
[5.8, 42.6 ]
0.01
Walk time (min) 6.2 (1.9) 6.7 (1.7) 0.5 (0.4)
[0.3, 0.7]
<0.001 6.0 (1.9) 6.3 (1.8) 0.3 (0.4)
[0.18, 0.5]
0.009
Fatigue Borg Scale
Beginning of walk 2.8 (2.4) 2.3 (1.7) −0.5 (1.5) 0.31 2.4 (2.6) 1.9 (2.3) −0.5 (1.1) 0.10
End of walk 4.8 (1.9) 3.3 (1.9) −1.5 (2.7) 4.1 (1.8) 3.5 (1.9) −0.4 (1.2)
Difference 2.0 (3.0) 1.0 (1.0) −1.0 (2.8) 0.13 1.4 (2.5) 1.5 (2.3) 0.2 (1.6) 0.64
Heart Rate (beats/min)
Beginning of walk 90.5 (16.6) 87.7 (13.5) −2.9 (10.2) 0.38 77.6 (13.9) 79.5 (15.4) 1.9 (6.3) 0.19
End of walk 100.6 (19.2) 101.2 (22.1) 0.5 (16.5) 87.5 (26.8) 88.3 (29.6) 0.8 (8.8)
Difference 10.1 (16.0) 13.5 (16.7) 3.4 (12.5) 0.15 9.9 (23.25) 8.8 (22.9) −1.1 (8.3) 0.64
Respiratory Rate (breaths/min)
Beginning of walk 17.4 (3.5) 16.0 (3.7) −1.4 (3.3) 0.17 15.5 (3.4) 15.4 (4.0) −0.1 (2.5) 0.95
End of walk 21.1 (3.0) 20.9 (4.9) −0.2 (4.1) 20.4 (6.2) 18.8 (5.2) −1.6 (4.0)
Difference 3.7 (4.1) 4.9 (5.3) 1.2 (6.4) 0.72 4.9 (4.4) 3.5 (4.1) −1.5 (3.8) 0.15
Systolic Blood pressure (mm Hg)
Beginning of walk 130.9 (19.4) 127.2 (18.3) −3.6 (15.0) 0.48 121.8 (18.7) 117.5 (16.9) −4.4 (12.7) 0.20
End of walk 142.4 (15.9) 145.7 (14.6) 3.3 (10.1) 131.4 (13.7) 136.3 (14.1) 4.9 (11.4)
Difference 11.5 (12.7) 18.5 (9.3) 6.9 (13.7) 0.10 9.5 (18.2) 18.8 (14.1) 9.3 (20.0) 0.10
Diastolic Blood pressure (mm Hg)
Beginning of walk 76.6 (11.7) 77.7 (6.8) 1.1 (7.0) 0.62 71.8 (10.6) 73.9 (11.0) 2.2 (6.0) 0.17
End of walk 81.5 (8.6) 85.9 (6.5) 4.4 (6.1) 75.4 (10.7) 78.2 (13.3) 2.8 (9.0)
Difference 4.9 (7.1) 8.2 (7.1) 3.3 (6.7) 0.11 3.6 (8.8) 4.2 (7.4) 0.7 (10.1) 0.44
Oxygen Saturation (%)
Beginning of walk 97.7 (1.4) 96.7 (2.1) −1 (1.2) 0.02 97.2 (2.0) 97.2 (2.2) 0.1 (1.5) 0.95
End of walk 97.9 (2.0) 97.6 (1.9) −0.3 (1.0) 97.9 (2.2) 97.9 (2.8) 0 (1.4)
Difference 0.2 (1.2) 0.9 (1.0) 0.7 (1.7) 0.21 0.7 (2.0) 0.7 (1.5) −0.1 (1.7) 0.87
Neurocognitive Testing
Before medication Post second walk test Difference P-value* Before medication Post second walk test Difference P-value*
Tapping 42.1 (9.9) 48.9 (11.2) 6.9 (8.6) 0.003 46.4 (8.4) 49.8 (9.1) 3.4 (6.3) 0.01
Arithmetic 88.7 (42.5) 84.8 (47.4) −3.9 (27.2) 0.56 52.8 (31.4) 58.1 (38.3) 5.2 (19.6) 0.73
Reverse digits 4.5 (2.1) 3.9 (2.4) −0.5 (1.6) 0.36 4.1 (2.1) 4.9 (2.6) 0.8 (1.7) 0.10
Visual 5.4 (1.2) 5.4 (1.3) 0 (1.4) >0.99 5.7 (0.8) 5.5 (0.9) −0.1 (0.9) >0.99

Abbreviations: CI, confidence interval; FSS, fentanyl sublingual spray; SD, standard deviation

*

Wilcoxon signed rank test was used for all comparisons between the first and second shuttle walk test.